Allergy drug shows promise for kidney protection in diabetes
NCT ID NCT05638880
First seen Apr 25, 2026 · Last updated May 11, 2026 · Updated 1 time
Summary
This study tested whether levocetirizine, a common allergy medication, can help reduce kidney damage in people with type 2 diabetes. The trial included 60 adults aged 40-65 who had early signs of diabetic kidney disease. Researchers measured changes in urine protein levels to see if the drug could protect kidney function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC NEPHROPATHIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mansoura University
Al Mansurah, 315511, Egypt
Conditions
Explore the condition pages connected to this study.